Cite

HARVARD Citation

    Alhumaid, M. et al. (n.d.). 112: Metastatic Melanoma Refractory to Immune-Checkpoint Inhibitors: Can Radiotherapy Improve the Immunotherapy Response?. Radiotherapy and oncology. pp. S48-S49. [Online]. 
  
Back to record